HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Aromatase inhibitors in recurrent ovarian endometriomas: report of five cases with literature review.

AbstractOBJECTIVE:
To determine the role of the aromatase inhibitor letrozole in the treatment of recurrent ovarian endometrioma cases.
DESIGN:
Nonrandomized proof of concept study.
SETTINGS:
Outpatient tertiary-care center.
PATIENT(S):
Five premenopausal patients with documented ovarian endometriomas and chronic pelvic pain, all of whom were previously treated with surgery and medicine with unsatisfactory results.
INTERVENTION(S):
Ovarian endometriomas were diagnosed by biopsy after laparoscopic ovarian cystectomy and subsequently treated with hormones. After a 6-month washout of endometriosis hormone therapies, women took letrozole (2.5 mg), one tablet of 0.15 mg of desogestrel, and 0.03 mg of ethinyl estradiol, calcium (1,200 mg), and vitamin D3 (800 IU) daily for 6 months.
MAIN OUTCOME MEASURE(S):
Size of endometriomas (monitored by ultrasound), assessment of pelvic pain (by visual analog scale), and bone density (DEXA scan).
RESULT(S):
Disappearance of ovarian endometrioma and reduction in pelvic pain in all cases at the end of 6 months. The size of ovarian endometriomas was reduced after 3 months. Pain scores decreased only after 1 month of treatment and continued decreasing in each treatment month. Overall, no significant change in bone density was detected.
CONCLUSION(S):
Letrozole given with combined pills achieved complete regression of recurrent endometriotic cysts and pain relief in all cases.
AuthorsSubrata Lall Seal, Gourisankar Kamilya, Joydev Mukherji, Alok De, Debdatta Ghosh, Arup Kr Majhi
JournalFertility and sterility (Fertil Steril) Vol. 95 Issue 1 Pg. 291.e15-8 (Jan 2011) ISSN: 1556-5653 [Electronic] United States
PMID20579642 (Publication Type: Case Reports, Journal Article, Review)
CopyrightCopyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Aromatase Inhibitors
  • Nitriles
  • Triazoles
  • letrozole
Topics
  • Adult
  • Aromatase Inhibitors (therapeutic use)
  • Endometriosis (drug therapy)
  • Female
  • Humans
  • Nitriles (therapeutic use)
  • Remission Induction
  • Triazoles (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: